Aspire Biopharma Holdings, Inc. - ASBP

Sector: Healthcare · Industry: Pharmaceutical Preparations
Website: No information yet · Social: No information yet

Company profile

Powered by TradingView

Quarter snapshot

Latest / Compare
Q4 2025 · Q3 2025
Value (USD)
Total reported value ($000)
$27.62M
QoQ value delta ($000)
-$14.77M (-34.85%)
Implied price effect (QoQ)
-70.18%
Shares
Total shares
6,823,464
QoQ shares delta
+3,700,421 (+118.49%)
Total shares held by funds (by quarter)
Shares (left)

Fund holders include prior positions carried forward until a new 13F confirms a change. Reported holders have reported a position in this security for that quarter; this is not the total number of 13F filers.

Market chart (ASBP)

Powered by TradingView
Interactive chart by TradingView.

Top holders (Q4 2025)

Top 25 only Full list
Early Q3 2026 data: only 1 institutional holders reported so far. More will appear as funds file with the SEC.
Manager Value ($000) Shares % of 13F
Antara Capital LP 26,762 202,897 88.65%
UBS Group AG 331 2,514,873 0.0%
Crewe Advisors LLC 107 813,427 0.01%
JANE STREET GROUP, LLC 90 688,143 0.0%
VANGUARD GROUP INC 56 428,552 0.0%
Optivise Advisory Services LLC 47 357,340 0.03%
XTX Topco Ltd 35 265,471 0.0%
GEODE CAPITAL MANAGEMENT, LLC 32 247,555 0.0%
Procyon Advisors, LLC 30 232,661 0.0%
Resolute Advisors LLC 20 155,826 0.01%
Three Seasons Wealth, LLC 16 125,000 0.0%
Virtu Financial LLC 14 108,791 0.0%
VR Advisory Services Ltd 12 97,391 0.0%
Verition Fund Management LLC 12 97,391 0.0%
EP Wealth Advisors, LLC 8 62,685 0.0%
P SCHOENFELD ASSET MANAGEMENT LP 7 58,563 0.0%
Avion Wealth 7 54,113 0.0%
CIBC Private Wealth Group LLC 6 49,129 0.0%
PERISCOPE CAPITAL INC. 6 50,000 0.0%
Scientech Research LLC 6 51,602 0.0%
VALLEY WEALTH MANAGERS, INC. 5 40,000 0.0%
Platform Technology Partners 4 37,611 0.0%
Crossingbridge Advisors, LLC 3 24,348 0.0%
Fisher Asset Management, LLC 1 10,000 0.0%
StoneX Group Inc. 1 14,675 0.0%